An explanation could come from the finding that RA metabolizing enzyme CYP26A1, which metabolizes RA, decreases RA signaling, and impedes cell differentiation, is also overexpressed in CRC cells [5] and other cancer types [6,7,8]. This evidence concerns the gene CYP26A1 and cancer.